文献速递呼吸危重症与机械通气

神经肌肉阻滞剂在21世纪危重症患者管理中的应用

Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
PubMed 文献 · Chest · 2016-11-03

本文综述神经肌肉阻滞剂(NMBA)在危重症患者通气和内科管理中的作用,指出2002年指南的担忧已被后续随机试验的新证据更新。现代ICU通过规范化路径、最小化镇静、加强监测和减少制动,使NMBA可安全用于气管插管、ARDS、哮喘持续状态等有限指征,但需充分镇静镇痛并监测麻痹深度。

要点

  • NMBA可在充分镇静镇痛下用于气管插管、ARDS、哮喘持续状态等有限指征。
  • 现代ICU的规范化路径、最小化镇静和监测技术提升使NMBA使用更安全。
  • 需监测麻痹深度并警惕 prolonged skeletal muscle weakness 等并发症。

核心结论

  • 在充分镇静镇痛和监测下,NMBA可考虑用于当前证据支持的少数危重症临床指征。

研究设计与样本

  • 本文为综述,回顾NMBA的作用机制、副作用和药理学,并评估其扩大的临床指征及监测与并发症。

主要发现

  • 2002年临床实践指南提出NMBA相关并发症的担忧,但后续随机试验和研究提供了更乐观的应用前景。
  • 现代ICU中规范化 care pathways、最小化或中断镇静、增加监测技术和减少制动等变化使NMBA可安全给药。
  • NMBA用于促进呼吸衰竭的肺保护性通气,并涉及气管插管、ARDS、哮喘持续状态、颅内压和腹内压增高及心脏骤停后治疗性低温等指征。

临床怎么用

  • 在充分镇静和镇痛背景下,可考虑监测下NMBA使用(持续或推注)于有当前证据支持的少数危重症指征。
  • 使用NMBA时应监测麻痹深度,并关注 prolonged skeletal muscle weakness 等并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Neuromuscular blockings agents (NMBAs) have a controversial role in the ventilatory and medical management of critical illness. The clinical concern surrounding NMBA-induced complications stems from evidence presented in the 2002 clinical practice guidelines, but new evidence from subsequent randomized trials and studies provides a more optimistic outlook about the application of NMBAs in the ICU. Furthermore, changes in the delivery of critical care, such as protocolized care pathways, minimizing or interrupting sedation, increased monitoring techniques, and overall improvements in reducing immobility, have created a modern, 21st century ICU environment whereby NMBAs may be administered safely. In this article we start with a review of the mechanism of action, side effects, and pharmacology of commonly used NMBAs. We then address the rationale for NMBA use for an expanding number of indications (endotracheal intubation, acute respiratory distress syndrome, status asthmaticus, increased intracranial and intra-abdominal pressure, and therapeutic hypothermia after cardiac arrest), with an emphasis on NMBA use in facilitating lung-protective ventilation for respiratory failure. We end with an appraisal over the importance of monitoring depth of paralysis and the concerns of complications, such as prolonged skeletal muscle weakness. In the context of adequate sedation and analgesia, monitored NMBA use (continuous or bolus administration) can be considered for the small number of clinical indications in critically ill patients for which evidence currently exists.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. deBacker J, Hart N, Fan E, et al. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient. Chest. 2016. PMID: 27818334. doi:10.1016/j.chest.2016.10.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。